Inhaling salbutamol may decrease time to exhaustion in some contexts of heavy endurance performances

References

• Andersen, A. B., Jacobson, G. A., Bejder, J., Premilovac, D., Richards, S. M., Rasmussen, J. J., et al. (2021). An abductive inference approach to assess the performance-enhancing effects of drugs included on the World Anti-Doping Agency prohibited list. Sports Medicine, 51(7), 1–24.
   Web of Science ®Google Scholar
• Andersen, K., & Kanstrup, I.-L. (2009). Effects Of acute oral administration Of 4 Mg salbutamol On exercise performance In Non-asthmatic elite athletes. Journal of Exercise Physiology Online, 12(1), 36–49.
   Google Scholar
• Borg, G., & Linderholm, H. (1967). Perceived exertion and pulse rate during graded exercise in various age groups. Acta Medica Scandinavica, 181(S472), 194–206.
   Google Scholar
• Carlsen, K. H., Ingjer, F., Kirkegaard, H., & Thyness, B. (1997). The effect of inhaled salbutamol and salmeterol on lung fuction and endurance performance in healthy well-trained athletes. Scandinavian Journal of Medicine & Science in Sports, 7(3), 160–165.
   PubMed Web of Science ®Google Scholar
• Collomp, K., Candau, R., Lasne, F., Labsy, Z., Prefaut, C., & De Ceaurriz, J. (2000). Effects of short-term oral salbutamol administration on exercise endurance and metabolism. Journal of Applied Physiology, 89(2), 430–436.
   PubMed Web of Science ®Google Scholar
• Fitch, K. (2016). The World Anti-Doping code: Can you have asthma and still be an elite athlete? Breathe, 12(2), 148–158.
   Google Scholar
• Heir, T., & Oseid, S. (1994). Self-reported asthma and exercise-induced asthma symptoms in high-level competitive cross-country skiers. Scandinavian Journal of Medicine & Science in Sports, 4(2), 128–133.
   Google Scholar
• Heir, T., & Stemshaug, H. (1995). Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes. Scandinavian Journal of Medicine & Science in Sports, 5(4), 231–236.
   PubMedGoogle Scholar
• Hopkins, W. G., Schabort, E. J., & Hawley, J. A. (2001). Reliability of power in physical performance tests. Sports Medicine, 31(3), 211–234.
   PubMed Web of Science ®Google Scholar
• Hostrup, M., Jessen, S., Backer, V., Bangsbo, J., & Jacobson, G. A. (2021). Beta2-adrenergic agonists can enhance intense performance and muscle strength in healthy individuals. Allergy, 76(7), 2318–2319.
   PubMed Web of Science ®Google Scholar
• Hostrup, M., Kalsen, A., Auchenberg, M., Bangsbo, J., & Backer, V. (2016). Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes. Scandinavian Journal of Medicine & Science in Sports, 26(1), 8–16.
   PubMed Web of Science ®Google Scholar
• Hostrup, M., Kalsen, A., Bangsbo, J., Hemmersbach, P., Karlsson, S., & Backer, V. (2014). High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men. European Journal of Applied Physiology, 114(12), 2499–2508.
   PubMed Web of Science ®Google Scholar
• Hostrup, M., Kalsen, A., Ørtenblad, N., Juel, C., Mørch, K., Rzeppa, S., et al. (2014). Β2-adrenergic stimulation enhances Ca2 + release and contractile properties of skeletal muscles, and counteracts exercise-induced reductions in Na+–K+-ATPase vmax in trained men. The Journal of Physiology, 592(24), 5445–5459.
   PubMed Web of Science ®Google Scholar
• Kalsen, A., Hostrup, M., Bangsbo, J., & Backer, V. (2014). Combined inhalation of beta2-agonists improves swim ergometer sprint performance but not high-intensity swim performance. Scandinavian Journal of Medicine & Science in Sports, 24(5), 814–822.
   PubMed Web of Science ®Google Scholar
• Kalsen, A., Hostrup, M., Söderlund, K., Karlsson, S., Backer, V., & Bangsbo, J. (2016). Inhaled Beta2-agonist increases power output and glycolysis during sprinting in Men. Medicine and Science in Sports and Exercise, 48(1), 39–48.
   PubMed Web of Science ®Google Scholar
• Larsson, K., Tornling, G., Gavhed, D., Muller-Suur, C., & Palmberg, L. (1998). Inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects. European Respiratory Journal, 12(4), 825–830.
   PubMed Web of Science ®Google Scholar
• Miller, M. D., & Ferris, D. G. (1993). Measurement of subjective phenomena in primary care research: The visual analogue scale. Family Practice Research Journal, 13(1), 15–24.
   PubMedGoogle Scholar
• Price, O. J., Hull, J. H., Backer, V., Hostrup, M., & Ansley, L. (2014). The impact of exercise-induced bronchoconstriction on athletic performance: A systematic review. Sports Medicine, 44(12), 1749–1761.
   PubMed Web of Science ®Google Scholar
• Riiser, A., Stensrud, T., Stang, J., & Andersen, L. B. (2020). Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs. British Journal of Sports Medicine, 54(22), 1351–1359.
   PubMed Web of Science ®Google Scholar
• Riiser, A., Stensrud, T., Stang, J., & Andersen, L. B. (2021). Aerobic performance among healthy (non-asthmatic) adults using beta2-agonists: A systematic review and meta-analysis of randomised controlled trials. British Journal of Sports Medicine, 55(17), 975–983.
   PubMed Web of Science ®Google Scholar
• Van Baak, M., De Hon, O., Hartgens, F., & Kuipers, H. (2004). Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. International Journal of Sports Medicine, 25(07), 533–538.
   PubMedGoogle Scholar
• van Baak, M. A., Mayer, L., Kempinski, R., & Hartgens, F. (2000). Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Medicine and Science in Sports and Exercise, 32(7), 1300–1306.
   PubMed Web of Science ®Google Scholar
• World-Anti-Doping-Agency. (2021). WADA statement on the salbutamol threshold/decision limit: WADA; Available from: https://www.wada-ama.org/sites/default/files/note_15may.pdf.
   Google Scholar